QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-constellation-brands-stock-today

Constellation Brands' stock rises despite revising FY25 EPS and sales forecasts and anticipating a significant non-cash goo...

 where-steris-stands-with-analysts
Where Steris Stands With Analysts
09/03/2024 16:00:22

 keybanc-maintains-overweight-on-steris-raises-price-target-to-265

Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $255 to $265.

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
08/08/2024 10:23:31

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 stephens--co-reiterates-overweight-on-steris-maintains-260-price-target

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $260 price target.

 steris-continues-to-expect-as-reported-revenue-from-continuing-operations-to-increase-65-75-in-fiscal-2025-adjusted-eps-to-be-in-the-range-of-905-925-vs-914-est

Fiscal 2025 Outlook Reiterated

 steris-q1-adj-203-beats-198-estimate

Steris (NYSE:STE) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.98 by 2.53 per...

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 these-10-large-cap-stocks-shined-brightest-last-week-may-5-may-11-2024-are-they-in-your-portfolio

Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in ...

 piper-sandler-reiterates-neutral-on-steris-raises-price-target-to-225

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Neutral and raises the price target from $220 to $225.

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
05/10/2024 10:06:12

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 steris-expects-fy25-as-reported-revenue-from-continuing-operations-to-increase-65-75-adjusted-eps-from-continuing-operations-of-905---925-est-933

Capital expenditures are anticipated to be approximately $360 million and free cash flow is expected to be approximately $700 m...

 steris-plans-restructuring-of-healthcare-surgical-business-in-europe-other-actions

STERIS today is also announcing a targeted restructuring plan, which includes restructuring of the Healthcare surgical business...

 steris-q4-2024-adj-eps-258-beats-235-estimate-sales-1419b-beat-1411b-estimate

Steris (NYSE:STE) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.35 by 9.79 per...

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
04/12/2024 08:39:39

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 steris-enters-definitive-deal-to-divest-its-dental-segment-to-peak-rock-capital-for-7875m

The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an ad...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION